179 related articles for article (PubMed ID: 3935135)
1. [In vitro activity of norfloxacin against gram-positive and gram-negative organisms from recent clinical isolates].
Mancini C; Brenciaglia MI; Ghezzi MC; Giordano A; Nazzari C; Cipriani P
Boll Ist Sieroter Milan; 1985; 64(4):289-93. PubMed ID: 3935135
[TBL] [Abstract][Full Text] [Related]
2. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of norfloxacin against 1700 relatively resistant clinical isolates.
Qadri SM; Lee G; Brodie L
Drugs Exp Clin Res; 1989; 15(8):349-53. PubMed ID: 2598776
[TBL] [Abstract][Full Text] [Related]
4. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
Piccolomini R; Allocati N; Catamo G
Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial effect of NSAIDS on clinical isolates of urinary tract infection and diabetic foot infection.
Akhter T; Baqai R; Aziz M
Pak J Pharm Sci; 2010 Jan; 23(1):108-13. PubMed ID: 20067876
[TBL] [Abstract][Full Text] [Related]
6. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
Drugs Exp Clin Res; 1987; 13(9):555-61. PubMed ID: 3480796
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates.
Esposito S; Galante D; Pennucci C; Barba D; Limauro D; Scioli C
Chemioterapia; 1984 Jun; 3(3):196-9. PubMed ID: 6241506
[TBL] [Abstract][Full Text] [Related]
9. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.
Chin NX; Neu HC
Am J Med; 1987 Apr; 82(4A):58-62. PubMed ID: 3578330
[TBL] [Abstract][Full Text] [Related]
10. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
Xiao QZ; Su DH; Jiang JH; Zhong NS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of extracts of Anthocleista djalonensis, Nauclea latifolia and Uvaria afzalii for activity against bacterial isolates from cases of non-gonococcal urethritis.
Okoli AS; Iroegbu CU
J Ethnopharmacol; 2004 May; 92(1):135-44. PubMed ID: 15099860
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity of amoxycillin/clavulanate (augmentin), ceftazidime and ceftriaxone against hospital strains of gram-negative and -positive bacteria.
Abd-Elalim Eltahawy AT; Khalaf RM
Chemioterapia; 1988 Apr; 7(2):75-8. PubMed ID: 3293818
[TBL] [Abstract][Full Text] [Related]
13. Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro.
Brothers AM; Gibbs PS; Wooley RE
Vet Ther; 2002; 3(4):493-500. PubMed ID: 12584687
[TBL] [Abstract][Full Text] [Related]
14. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1991). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Oct; 48(10):1394-421. PubMed ID: 8544337
[TBL] [Abstract][Full Text] [Related]
15. [Susceptibility in vitro to certain quinolines of gram-negative bacteria and gram-positive cocci causing urinary tract infections].
Mróz E; Jankowski S; Bartelmus J; Grzybek-Hryncewicz K; Ruczkowska J; Starek J; Boratyńska M
Med Dosw Mikrobiol; 1993; 45(1):115-8. PubMed ID: 8231429
[TBL] [Abstract][Full Text] [Related]
16. [Antimicrobial susceptibilities of organisms isolated from patients with urinary tract infections in 2002].
Eta S; Kawahara M
Jpn J Antibiot; 2006 Feb; 59(1):21-8. PubMed ID: 16673579
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT
J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
Debbia E; Schito GC; Nicoletti G; Speciale A
Chemioterapia; 1987 Oct; 6(5):319-23. PubMed ID: 3480779
[TBL] [Abstract][Full Text] [Related]
19. Influence of the cell wall on ciprofloxacin susceptibility in selected wild-type Gram-negative and Gram-positive bacteria.
Berlanga M; Montero MT; Hernández-Borrell J; Viñas M
Int J Antimicrob Agents; 2004 Jun; 23(6):627-30. PubMed ID: 15194135
[TBL] [Abstract][Full Text] [Related]
20. [Statistic studies on bacteria isolated from urinary tract infections (report 6: isolation rate and drug sensitivity from 1988 through 1989)].
Okada K; Usui Y; Abe T; Watanabe S; Ishida T; Arihara K; Masuda A; Inatsuchi H; Tanaka M; Hihara T
Hinyokika Kiyo; 1994 Feb; 40(2):175-85. PubMed ID: 8128931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
